These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 30153136

  • 1. Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose metabolism.
    Rom O, Villacorta L, Zhang J, Chen YE, Aviram M.
    Curr Opin Lipidol; 2018 Oct; 29(5):428-432. PubMed ID: 30153136
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bibliography. Current world literature. Nutrition and metabolism.
    Curr Opin Lipidol; 2009 Feb; 20(1):63-72. PubMed ID: 19106709
    [No Abstract] [Full Text] [Related]

  • 5. Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges.
    Zhang Y, Zhang XJ, Li H.
    Curr Drug Targets; 2017 Feb; 18(15):1754-1778. PubMed ID: 26240052
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Osteoblastic responses to LPS, glucose-oxidised LDL and minocycline: therapeutic targets for periodontal and cardiometabolic diseases.
    Tilakaratne A, Soory M.
    Recent Pat Endocr Metab Immune Drug Discov; 2012 Jan; 6(1):73-84. PubMed ID: 22280224
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sortilin and Its Multiple Roles in Cardiovascular and Metabolic Diseases.
    Goettsch C, Kjolby M, Aikawa E.
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):19-25. PubMed ID: 29191923
    [Abstract] [Full Text] [Related]

  • 17. Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.
    Zhang SY, Xu MJ, Wang X.
    Br J Pharmacol; 2018 Apr; 175(8):1230-1240. PubMed ID: 28407200
    [Abstract] [Full Text] [Related]

  • 18. Impact of tobacco smoking on lipid metabolism, body weight and cardiometabolic risk.
    Gastaldelli A, Folli F, Maffei S.
    Curr Pharm Des; 2010 Apr; 16(23):2526-30. PubMed ID: 20550509
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The therapy of lipid metabolic disorders].
    Windler E, Greten H.
    Dtsch Med Wochenschr; 1991 Feb 01; 116(5):181-5. PubMed ID: 1993423
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.